Filter
868
Text search:
Antigen
testing
Featured
Recommendations
127
New Publications
227
Language
Document type
No document type
447
Guidelines
198
Studies & Reports
91
Manuals
46
Fact sheets
34
Strategic & Response Plan
30
Training Material
9
Resource Platforms
4
Situation Updates
3
Online Courses
3
Infographics
2
Videos
1
Countries / Regions
India
55
Global
30
South Africa
23
Nigeria
20
Kenya
19
Africa
19
Western and Central Europe
17
Tanzania
16
Zambia
14
East and Southern Africa
14
Sierra Leone
13
Philippines
13
Uganda
12
Germany
12
West and Central Africa
12
Nepal
11
Rwanda
11
Ukraine
11
Liberia
10
Malawi
10
Russia
10
Ghana
9
Latin America and the Carribbean
9
Ethiopia
8
Zimbabwe
8
Namibia
8
Middle East and North Africa
7
Myanmar / Burma
6
Eastern Europe and Central Asia
6
Congo, Democratic Republic of
5
Syria
5
Bangladesh
5
USA
4
Cambodia
4
Mozambique
4
Brazil
4
Eastern Europe
4
Saudi Arabia
3
Cameroon
3
Indonesia
3
Lesotho
3
South–East Asia Region
3
Albania
3
Burkina Faso
2
Somalia
2
Pakistan
2
Iraq
2
Jordan
2
Lebanon
2
Sudan
2
Eswatini/ Swaziland
2
Colombia
2
Libya
2
Asia
2
Iran
2
Guinea
1
Mali
1
Morocco
1
Haiti
1
South Sudan
1
Afghanistan
1
Egypt
1
China
1
Central African Republic
1
Peru
1
North Macedonia
1
Ecuador
1
Botswana
1
Greece
1
Angola
1
Madagascar
1
Chile
1
Yemen
1
Palestine
1
Djibouti
1
Qatar
1
Moldova
1
Kazakhstan
1
Georgia
1
North America
1
Tunisia
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
323
Clinical Guidelines
130
Pharmacy & Technologies
42
Public Health
26
Women & Child Health
18
Key Resources
17
Capacity Building
7
Toolboxes
COVID-19
170
HIV
123
TB
58
Rapid Response
55
NTDs
45
Ebola
36
Refugee
15
Pharmacy
15
Zika
12
AMR
11
Conflict
10
Caregiver
10
Cholera
7
Mental Health
6
Polio
4
Planetary Health
4
Natural Hazards
3
NCDs
3
Global Health Education
2
Health Financing Toolbox
2
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
Временные рекомендации27 мая 2021 г.
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators
...
16.7.2021
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Quick reference guide
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
This document offers public health guidance for the prevention and control of COVID-19 in reception centres, and other temporary accommodation facilities, in the context of the mass influx of Ukrainian people into the European Union (EU), the European Economic Area (EEA) and the Republic of Moldova.
...
Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several
regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting
of anonymized, patient-level data of acute hepatitis of unknown aetiology.
This annual report highlights the work of the WHO from January to June 2021 ( December 2021). The activities featured herein are by no means exhausted but implemented with technical and financial support through WHO in Nigeria; facilitated by its presence at all levels of governance (national, state
...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k
...
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
Diphtheria is caused by Corynebacterium species, mostly by toxin-producing Corynebacterium diphtheriae and rarely by toxin-producing strains of C. ulcerans and C. pseudotuberculosis. The most common type of diphtheria is classic respiratory diphtheria, whereby the exotoxin produced characteristicall
...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i
...
